FDA Approval Anticipated for Weight Loss Drugs by 2026 | Retatrutide News

BusinessWorld Online reports that FDA approval for weight loss drugs including retatrutide is expected by 2026. Eli Lilly is advancing its metabolic pip...
Market News · October 23, 2026